|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Zhang G, Li X, Li B and Zhang X:
The effect of ribosomal protein S15a in lung adenocarcinoma. PeerJ.
4:e17922016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Riley T, Sontag E, Chen P and Levine A:
Transcriptional control of human p53-regulated genes. Nat Rev Mol
Cell Biol. 9:402–412. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gu J, Wang B, Liu Y, Zhong L, Tang Y, Guo
H, Jiang T, Wang L, Li Y and Cai L: Murine double minute 2 siRNA
and wild-type p53 gene therapy interact positively with zinc on
prostate tumours in vitro and in vivo. Eur J Cancer. 50:1184–1194.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji K, Wang B, Shao YT, Zhang L, Liu YN,
Shao C, Li XJ, Li X, Hu JD, Zhao XJ, et al: Synergistic suppression
of prostatic cancer cells by coexpression of both murine double
minute 2 small interfering RNA and wild-type p53 gene in vitro and
in vivo. J Pharmacol Exp Ther. 338:173–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ayroldi E, Petrillo MG, Bastianelli A,
Marchetti MC, Ronchetti S, Nocentini G, Ricciotti L, Cannarile L
and Riccardi C: L-GILZ binds p53 and MDM2 and suppresses tumor
growth through p53 activation in human cancer cells. Cell Death
Differ. 22:118–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu J, Tang Y, Liu Y, Guo H, Wang Y, Cai L,
Li Y and Wang B: Murine double minute 2 siRNA and wild-type p53
gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer
cell line to cisplatin chemotherapy in vitro and in vivo. Cancer
Lett. 343:200–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo H, Li Y, Gu J, Wang Y, Liu L, Zhang P
and Liu Y: Effect of vascular endothelial growth factor siRNA and
wild-type p53 co-expressing plasmid in MDA-MB-231 cells. Mol Med
Rep. 13:461–468. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elmetwali T, Salman A and Palmer DH:
NORE1A induction by membrane-bound CD40L (mCD40L) contributes to
CD40L-induced cell death and G1 growth arrest in p21-mediated
mechanism. Cell Death Dis. 7:e21462016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng QH, Ma LW, Zhu WG, Zhang ZY and Tong
TJ: p21Waf1/Cip1 plays a critical role in modulating senescence
through changes of DNA methylation. J Cell Biochem. 98:1230–1248.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hensing T, Chawla A, Batra R and Salgia R:
A personalized treatment for lung cancer: molecular pathways,
targeted therapies, and genomic characterization. Adv Exp Med Biol.
799:85–117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang HQ, Jin JJ and Wang J: Arctigenin
enhances chemosensitivity to cisplatin in human nonsmall lung
cancer H460 cells through downregulation of survivin expression. J
Biochem Mol Toxicol. 28:39–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Wang X, Chen T and Qu J: p38
inhibitor SB203580 sensitizes the resveratrol-induced apoptosis in
human lung adenocarcinoma (A549) cells. J Biochem Mol Toxicol.
26:251–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vassilev LT, Vu BT, Graves B, Carvajal D,
Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, et
al: In vivo activation of the p53 pathway by small-molecule
antagonists of MDM2. Science. 303:844–848. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shinohara T and Uesugi M: In-vivo
activation of the p53 pathway by small-molecule antagonists of
MDM2. Tanpakushitsu Kakusan Koso. 52(13 Suppl): S1816–S1817.
2007.(In Japanese).
|
|
16
|
Marine JC and Lozano G: Mdm2-mediated
ubiquitylation: P53 and beyond. Cell Death Differ. 17:93–102. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Zhang C, Wang XL, Ly P, Belyi V,
Xu-Monette ZY, Young KH, Hu W and Feng Z: E3 ubiquitin ligase
TRIM32 negatively regulates tumor suppressor p53 to promote
tumorigenesis. Cell Death Differ. 21:1792–1804. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harris SL and Levine AJ: The p53 pathway:
Positive and negative feedback loops. Oncogene. 24:2899–2908. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pajalunga D, Mazzola A, Salzano AM, Biferi
MG, De Luca G and Crescenzi M: Critical requirement for cell cycle
inhibitors in sustaining nonproliferative states. J Cell Biol.
176:807–818. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Odkhuu E, Mendjargal A, Koide N, Naiki Y,
Komatsu T and Yokochi T: Lipopolysaccharide downregulates the
expression of p53 through activation of MDM2 and enhances
activation of nuclear factor-kappa B. Immunobiology. 220:136–141.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valesky EM, Hrgovic I, Doll M, Wang XF,
Pinter A, Kleemann J, Kaufmann R, Kippenberger S and Meissner M:
Dimethylfumarate effectively inhibits lymphangiogenesis via p21
induction and G1 cell cycle arrest. Exp Dermatol. 25:200–205. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SY, Kim JE, Lee KW and Lee HJ:
Lactococcus lactis ssp. lactis inhibits the proliferation of SNU-1
human stomach cancer cells through induction of G0/G1 cell cycle
arrest and apoptosis via p53 and p21 expression. Ann N Y Acad Sci.
1171:270–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chu K, Gao G, Yang X, Ren S, Li Y, Wu H,
Huang Y and Zhou C: miR-512-5p induces apoptosis and inhibits
glycolysis by targeting p21 in non-small cell lung cancer cells.
Int J Oncol. 48:577–586. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Baharuddin P, Satar N, Fakiruddin KS,
Zakaria N, Lim MN, Yusoff NM, Zakaria Z and Yahaya BH: Curcumin
improves the efficacy of cisplatin by targeting cancer stem-like
cells through p21 and cyclin D1-mediated tumour cell inhibition in
non-small cell lung cancer cell lines. Oncol Rep. 35:13–25. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Devany E, Zhang X, Park JY, Tian B and
Kleiman FE: Positive and negative feedback loops in the p53 and
mRNA 3′ processing pathways. Proc Natl Acad Sci USA. 110:pp.
3351–3356. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang Y, Cui Y, Li Z, Jiao Z, Zhang Y, He
Y, Chen G, Zhou Q, Wang W, Zhou X, et al: Radiation-induced
miR-208a increases the proliferation and radioresistance by
targeting p21 in human lung cancer cells. J Exp Clin Cancer Res.
35:72016. View Article : Google Scholar : PubMed/NCBI
|
